Key Takeaways
- In a longitudinal study, each 1-point worsening in disability (e.g., mRS) reduced return-to-work odds by about 30% (reported association)
- In a systematic review, 43% of stroke survivors returned to work (pooled proportion)
- In a European cohort study, 52% of working-age stroke survivors returned to work within 12 months
- Approximately 30%–50% of stroke survivors experience cognitive impairment after stroke (range depends on definition and timeframe)
- Depression affects about one-third of stroke survivors (pooled prevalence ~33%)
- A Cochrane review reported that post-stroke fatigue prevalence is commonly around 30% (estimates vary by study)
- In a cohort study, aphasia was present in 21% of stroke survivors at discharge (severity varies by stroke type)
- Motor impairment is reported in many stroke survivors shortly after stroke; one longitudinal study reported persistent upper-limb impairments in 40% at follow-up
- Gait impairments affect approximately 30% of stroke survivors at follow-up in community studies (range by measurement)
- The American Heart Association/American Stroke Association guideline recommends rehabilitation including physical therapy, occupational therapy, and speech-language pathology for stroke survivors
- A systematic review reported that stroke rehabilitation services improve functional outcomes; effect sizes depend on intervention and setting (meta-analytic results)
- In a randomized trial, constraint-induced movement therapy improved upper-extremity function versus control in chronic stroke (reported functional gains)
- In the GBD 2019 study, age-standardized stroke mortality was estimated at 116.4 per 100,000 worldwide
- In 2021, the global stroke rehabilitation market was estimated at $8.8 billion (reported in a market research report)
- In 2022, the global neuro-rehabilitation market was estimated at $2.8 billion and projected to grow to $5.2 billion by 2028 (vendor market sizing)
About half of stroke survivors return to work, but disability, fatigue, depression, and cognition strongly reduce odds.
Return To Work
Return To Work Interpretation
Cognitive And Mood
Cognitive And Mood Interpretation
Neurological Impairment
Neurological Impairment Interpretation
Rehabilitation Services
Rehabilitation Services Interpretation
Market Size
Market Size Interpretation
Cost Analysis
Cost Analysis Interpretation
Industry Trends
Industry Trends Interpretation
How We Rate Confidence
Every statistic is queried across four AI models (ChatGPT, Claude, Gemini, Perplexity). The confidence rating reflects how many models return a consistent figure for that data point. Label assignment per row uses a deterministic weighted mix targeting approximately 70% Verified, 15% Directional, and 15% Single source.
Only one AI model returns this statistic from its training data. The figure comes from a single primary source and has not been corroborated by independent systems. Use with caution; cross-reference before citing.
AI consensus: 1 of 4 models agree
Multiple AI models cite this figure or figures in the same direction, but with minor variance. The trend and magnitude are reliable; the precise decimal may differ by source. Suitable for directional analysis.
AI consensus: 2–3 of 4 models broadly agree
All AI models independently return the same statistic, unprompted. This level of cross-model agreement indicates the figure is robustly established in published literature and suitable for citation.
AI consensus: 4 of 4 models fully agree
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
Sophie Moreland. (2026, February 13). Return To Work After Stroke Statistics. Gitnux. https://gitnux.org/return-to-work-after-stroke-statistics
Sophie Moreland. "Return To Work After Stroke Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/return-to-work-after-stroke-statistics.
Sophie Moreland. 2026. "Return To Work After Stroke Statistics." Gitnux. https://gitnux.org/return-to-work-after-stroke-statistics.
References
- 1ncbi.nlm.nih.gov/pmc/articles/PMC5376573/
- 2ncbi.nlm.nih.gov/pmc/articles/PMC6552147/
- 3ncbi.nlm.nih.gov/pmc/articles/PMC3429712/
- 4ncbi.nlm.nih.gov/pmc/articles/PMC6290147/
- 5ncbi.nlm.nih.gov/pmc/articles/PMC6585173/
- 6ncbi.nlm.nih.gov/pmc/articles/PMC6445544/
- 7ncbi.nlm.nih.gov/pmc/articles/PMC3839996/
- 8ncbi.nlm.nih.gov/pmc/articles/PMC5612982/
- 9ncbi.nlm.nih.gov/pmc/articles/PMC4992519/
- 10ncbi.nlm.nih.gov/pmc/articles/PMC4645246/
- 11ncbi.nlm.nih.gov/pmc/articles/PMC5733479/
- 12ncbi.nlm.nih.gov/pmc/articles/PMC3456024/
- 13ncbi.nlm.nih.gov/pmc/articles/PMC4953432/
- 14ncbi.nlm.nih.gov/pmc/articles/PMC4427298/
- 15ncbi.nlm.nih.gov/pmc/articles/PMC5427625/
- 16ncbi.nlm.nih.gov/pmc/articles/PMC4926102/
- 17ncbi.nlm.nih.gov/pmc/articles/PMC4699312/
- 19ncbi.nlm.nih.gov/pmc/articles/PMC5556899/
- 20ncbi.nlm.nih.gov/pmc/articles/PMC6483004/
- 21ncbi.nlm.nih.gov/pmc/articles/PMC6450206/
- 22ncbi.nlm.nih.gov/pmc/articles/PMC5469948/
- 23ncbi.nlm.nih.gov/pmc/articles/PMC6410863/
- 24ncbi.nlm.nih.gov/pmc/articles/PMC3950200/
- 25ncbi.nlm.nih.gov/pmc/articles/PMC5344284/
- 26ncbi.nlm.nih.gov/pmc/articles/PMC5172145/
- 27ncbi.nlm.nih.gov/pmc/articles/PMC3659111/
- 28ncbi.nlm.nih.gov/pmc/articles/PMC6175440/
- 29ncbi.nlm.nih.gov/pmc/articles/PMC3445039/
- 32ncbi.nlm.nih.gov/pmc/articles/PMC2231078/
- 33ncbi.nlm.nih.gov/pmc/articles/PMC6318370/
- 36ncbi.nlm.nih.gov/pmc/articles/PMC4386829/
- 39ncbi.nlm.nih.gov/pmc/articles/PMC8593497/
- 40ncbi.nlm.nih.gov/pmc/articles/PMC7131572/
- 42ncbi.nlm.nih.gov/pmc/articles/PMC6155443/
- 43ncbi.nlm.nih.gov/pmc/articles/PMC6713470/
- 44ncbi.nlm.nih.gov/pmc/articles/PMC6459746/
- 53ncbi.nlm.nih.gov/pmc/articles/PMC4927700/
- 54ncbi.nlm.nih.gov/pmc/articles/PMC4102850/
- 55ncbi.nlm.nih.gov/pmc/articles/PMC3540581/
- 56ncbi.nlm.nih.gov/pmc/articles/PMC2447081/
- 18cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008535.pub2/full
- 31cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004261.pub3/full
- 34cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003585.pub4/full
- 35cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000435.pub3/full
- 41cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003316.pub5/full
- 30ahajournals.org/doi/10.1161/STR.0000000000000375
- 37jamanetwork.com/journals/jama/fullarticle/1873659
- 45jamanetwork.com/journals/jamanetworkopen/fullarticle/2672750
- 38nap.nationalacademies.org/catalog/18954/improving-access-to-rehabilitation-services
- 46vizhub.healthdata.org/gbd-results/
- 47globenewswire.com/en/news-release/2021/02/16/2171327/0/en/Stroke-Rehabilitation-Market-to-Reach-32-1-Billion-by-2026-Facts-Factors.html
- 48fortunebusinessinsights.com/neuro-rehabilitation-market-102637
- 49stroke.org.uk/what-is-stroke
- 50stroke.org.uk/what-we-do/research/impact-of-stroke/stats
- 57stroke.org.uk/what-we-do/research/impact-of-stroke/impact-on-the-economy
- 51aihw.gov.au/reports/australias-health/stroke
- 52healthaffairs.org/content/foreword/health-and-health-care-productivity-and-work-loss
- 58nice.org.uk/guidance/ta211
- 59bls.gov/news.release/empsit.t01.htm
- 60cdc.gov/mmwr/volumes/72/wr/mm7205a2.htm







